Prudential Financial Inc Aravive, Inc. Transaction History

Prudential Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.11 - $1.76 $28,578 - $457,248	259,800 New	259,800 $33,000
Q2 2021 Aug 16, 2021	SELL	$4.65 - $6.42 $127,270 - $175,715	-27,370 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$5.11 - $9.24 $139,860 - $252,898	27,370 New	27,370 $180,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.